Oslo University Hospital (OUS)
Phase/Capacity:
All phases, extensive experience with trials, good capacity
Facilities:
- Amyloid and FDG-PET
- Lumbar puncture
- 3T/1.5T MRI
- Dedicated research nurses
Other:
Experience with infusion therapy
Helse Bergen, Haukeland University Hospital (HUS) / Haraldsplass Deaconessal Hospital
Phase/Capacity:
Phase I–IV
Evaluates individuals across the entire age spectrum and receives approximately 600 new referrals annually. We have a dedicated research unit for clinical trials that includes individuals with Alzheimer's disease/dementia, with dedicated nurses, biomedical laboratory scientists, and physicians continuously updated on ICH-GCP. Participates in several academic studies and one industry sponsored study. Capable of handling demanding study protocols. Has cohort studies that function as “trial-ready populations”.
Facilities:
- FDG-PET
- MRI
- DAT imaging, spinal tap
- Lumbal puncture
Other:
Experience with infusion therapy. Can perform intrathecal administration.
Akershus University Hospital (Ahus), Lørenskog
Phase/Capacity:
All phases (experience with studies from phase I-III). The neurology department prioritises the assessment and diagnostic evaluation of mild cognitive impairment in patients under 80 years old and has a dedicated observation cohort for pre-dementia patients along with a high number of newly referred patients as a base for recruitment.
Facilities:
Amyloid and FDG PET, 3T/1.5T MRI, cerebrospinal fluid examinations, and blood-based markers in routine or research lab.
The neurology department has an interdisciplinary staffed memory clinic, including neuropsychologists and research nurses, etc.
Other:
The department has infusion units available for day-care treatment, or if admitted, for longer monitoring if needed.
St. Olav's Hospital (Trondheim)
Phase/Capacity:
Department of Geriatrics:
All phases, wishes to prioritise participation in research.
Provides assessment and diagnostic evaluation of cognitive impairment in individuals aged 65 years and older. Good collaboration with the department of neurology and the department of geriatric psychiatry, ensuring good access to potential study patients.
Department of Neurology:
Phase II–IV
Provides assessment and diagnostic evaluation of younger individuals with cognitive impairment (under 70 years) and/or neurodegenerative diseases associated with other focal neurological deficits.
All patients referred for cognitive assessment are offered enrollment in the dedicated research cohort; Trønderbrain. This also includes collection and storage of biological samples (biobanking). Trønderbrain also includes healthy controls for the research project, see website for more info.
The department of neurology and Trønderbrain are also part of the National Association's Dementia Research Centre.
Facilities:
- PET-MRI (for research: FDG, amyloid, tau) or PET-CT if contraindicated for MRI
- Cyclotron
- 7T MRI
- Lumbar puncture
Stavanger University Hospital (SUS), SESAM Department
Phase/Capacity:
All phases of clinical trials. Good capacity. Sponsor role in several national and international academic trials.
SESAM has a close collaboration between the Geriatric and Geriatric Psychiatric outpatient clinics, ensuring good access to patients undergoing early assessment and strengthening recruitment in clinical trials.
Study personnel with ICH-GCP R3 certification and extensive clinical research experience. The team includes a full-time physician serving as Principal Investigator (PI), six study nurses, one of whom has advanced clinical nursing education (AKS). Additionally, the department has a study coordinator with substantial experience in regulatory application processes.
Facilities:
- FDG-PET
- EEG
- CSF
- MRI
- DaTSCAN
- Biobank
- Research unit
Other:
Experience with infusion therapy
University Hospital of North Norway, Tromsø
Phase/Capacity:
All phases, prioritising phase III–IV
Facilities:
Amyloid PET for research and all other needs (does not have Tau PET)
Helse Fonna, Haugesund Hospital
Phase/Capacity:
The Elderly Medicine Outpatient Clinic has experience from several cohort studies and phase II trials, leads the ANeED study, and participates in the FEAD and NA-D studies. Currently has some available capacity for industry sponsored clinical trials.
Facilities:
- MRI
- DaTSCAN
- Lumbar puncture
- EEG
- FDG-PET referred to Bergen or Stavanger
Other:
Planning to start infusion therapy. Research nurses and Research biomedical scientists.
Østfold Hospital, Kalnes
Phase/Capacity:
Has the capacity for all phases, but primarily wishes for phase III–IV.
Good capacity.
High proportion of staff with ICH-GCP R3. Study nurse.
Facilities:
- PET FDG
- EEG and flutemetamol
- Lumbar puncture
Other:
From 1 September 2026: all patients under 65 years with cognitive difficulties will be assessed first by a neurologist, and then by a geriatrician. Patients aged 65 and over will primarily be assessed by a geriatrician. Good collaboration.
Experience with infusion therapy.
Vestre Viken, Kongsberg Hospital
Phase/Capacity:
The site is interested in participating in phase III–IV clinical trials.
Local hospital with a Geriatric outpatient clinic. Some variation in nursing capacity. Good capacity for assessment and diagnostic evaluation of cognitive impairment, geriatric outpatient clinic. Limited experience with clinical trials so far, only referred candidates to Oslo University Hospital.
Facilities:
- MRI
- Lumbar puncture
- DaTSCAN and FDG PET (the latter two only sent to Drammen)
Other:
The day-care treatment unit may assist if needed.
This page was translated from Norwegian using Optimizely auto-translate and reviewed by Ellen Johnsen.